Research
Adolescent brain development
Appointments
- Assistant Professor, Neuroscience IDP
- Psychology
- Behavioral Neuroscience
- Developmental Psychology
- Member, Brain Research Institute
Biography
Dr. Galván’s work is broadly focused on identifying key neural circuits that are disrupted in children and adolescents with developmental disabilities. She uses magnetic resonance imaging, functional magnetic resonance imaging, and behavioral methods to address questions regarding typical and atypical brain development.
Most recently, she has focused her efforts on elucidating neural correlates of cognitive control and inhibition in children with Attention Deficit Hyperactivity Disorder, Tic Disorder, Generalized Anxiety Disorder and Social Anxiety Disorder.
Publications
- Kamarajah, SK, Adisa, AO, Aggarwal, A, Berhe, A, Glasbey, J, Harrison, E et al.. Evaluating quality of colorectal cancer surgery across elective and emergency health systems: secondary analysis of prospective cohort studies in 95 countries. BJS Open. 2026;10 (4):. doi: 10.1093/bjsopen/zrag062. PubMed PMID:42483900 .
- Hernández, J, Uy, J, Eisenberger, NI, Galván, A, Telzer, EH, Fuligni, AJ et al.. Neural representations of the value of helping the family during adolescence. Dev Cogn Neurosci. 2026;80 :101770. doi: 10.1016/j.dcn.2026.101770. PubMed PMID:42391900 PubMed Central PMC13352427.
- Bick, J, Li, X, Laughlin, H, Jimenez Ortiz, A, Galvan, A, Vaughn, K et al.. Atypical neural responses to dynamically changing facial expressions correlate with behavioral risk in toddlers born preterm: Evidence from an ERP study. Neuroimage Rep. 2026;6 (2):100333. doi: 10.1016/j.ynirp.2026.100333. PubMed PMID:42326061 PubMed Central PMC13282526.
- Laughlin, H, Galvan, A, Ortiz-Jimenez, A, Li, X, Knudtson, M, Barry, K et al.. Individual variability in neural correlates of visual engagement in premature toddlers. Dev Cogn Neurosci. 2026;79 :101731. doi: 10.1016/j.dcn.2026.101731. PubMed PMID:42092393 PubMed Central PMC13158708.
- Yu, K, Tidwell, RS, Bathala, TK, Sheth, RA, Karki, M, Chen, J et al.. Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma. Clin Cancer Res. 2026;32 (10):1946-1961. doi: 10.1158/1078-0432.CCR-25-4518. PubMed PMID:42007903 .